http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080012077-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_717c792fca7cc9c290c9db33e8fe078b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-328 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-403 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-235 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2006-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2163d94e868235d65dc91dad33e3d4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20cd25c644ae9b5a6a7388d771195476 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_393a54b05bed77fef27a3868e8a7d5f9 |
| publicationDate | 2008-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20080012077-A |
| titleOfInvention | Pharmaceutical Compositions, Health Food Compositions, and Panasonic X Nuclear Receptor Inhibitor Compositions Containing Scalar Lane Sesterterpins |
| abstract | The present invention is a metabolic disorder, such as diabetes mellitus, obesity, hypercholesterolemia, hyperlipoproteinemia, and hyperlipidemia, arteriosclerosis, hypertension, circulatory disease, etc. using the scalarane-based sesterterpenes compound as an active ingredient. The present invention relates to a pharmaceutical composition for the prevention or treatment of overeating, ischemic heart disease, and a health food composition and a composition for inhibiting farnesoid X-activated receptor activity, the scalarane-based sesterterpenes The compound is characterized in that it is isolated and purified from sponge sponge spongia ( Spongia sp.).n n n The composition according to the present invention is useful for treating and preventing cholesterol metabolic diseases and hyperlipidemia by inhibiting the activity of farnesoid X-activated receptors (FXRs) to effectively lower cholesterol levels in the liver. |
| priorityDate | 2006-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 216.